News

A US-based doctor has shared three signs of a heart attack that everyone must know, including a less common symptom that ...
Researchers from the Germans Trias i Pujol research institute (IGTP) have conducted a preclinical study on the effects of the ...
For patients with T2D, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and CV event risks.
Patients with history of preeclampsia have increased risk for myocardial infarction and worse myocardial infarction outcomes.
A new study analyzing data from millions of patients shows significant links between cannabis use and major adverse ...
Bottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney ...